SELLAS Life Sciences Group, Inc. — Director's Dealing 2013

Dec 17, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2013-11-26

Reporting Person: HAMILTON BRIAN L (EVP & Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-11-26	Stock Option (right to buy)	$3.88	A	300000	Acquired	2023-11-26	Common Stock (300000)	Direct

Footnotes

F1: Granted pursuant to the Issuer's Amended and Restated 2007 Incentive Plan.

F2: Option vests in 12 quarterly installments of 25,000 shares each over three years, beginning on the first quarterly anniversary of the grant date, as long as Reporting Person remains continuously employed by the Issuer through such quarterly anniversary dates.